The integration of pre-screening all patients for eligibility in oncology studies.
Natasha Blakeney, MPH
Advertisement
Articles by Natasha Blakeney, MPH
Physician participation in and patient access to cancer treatment clinical trials (CCTs) are key measures for delivery of quality cancer care.
Advertisement
Latest Updated Articles
Making a Difference in Cancer Trials AccrualPublished: April 1st 2014 | Updated:
Making a Difference in Clinical Trials Accrual: The Integration of Prescreening All Patients for EligibilityPublished: November 8th 2013 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials
2
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
3
Honing the Power of AI for Next Generation Trial Oversight and Execution
4
Driving Collaboration Across Functions to Streamline Drug Development
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
